SCHEMBL20613656

SCHEMBL20613656

COc1cc(OCc2ccccc2)cc2oc(-c3cc#ccc3)cc(=O)c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ KDM4E B2RXH2 3/20 0.57
▸ ABCG2 Q9UNQ0 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ ABCB1 P08183 3/20 0.56
▸ MAPT P10636 2/20 0.56
▸ PPARG P37231 4/20 0.55
▸ CYP1A1 P04798 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP1B1 Q16678 1/20 0.51
▸ BCHE P06276 1/20 0.49
▸ ACHE P22303 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ AR P10275 1/20 0.48
▸ HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30376090 0.87 L3MBTL1 (0.77) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL19267888 0.87 L3MBTL1 (0.77) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL8064295 0.83 L3MBTL1 (0.71) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL8066758 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL29979584 0.82 L3MBTL1 (0.79) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL1421600 0.78 ABCG2 (0.67) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL4268322 0.77 L3MBTL1 (1.00) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL7306849 0.76 MAPT (0.74) L3MBTL1ABCG2ALDH1A1MEN1KMT2A
SCHEMBL18526951 0.75 ABCG2 (0.65) L3MBTL1KDM4EABCG2ALDH1A1MEN1
SCHEMBL738489 0.75 MEN1 (0.71) L3MBTL1ABCG2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421035-A1 NOVEL USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING FIBROSIS BY USING EPITHELIAL-MESENCHYMAL TRANSITION INHIBITORY ACTIVITY THEREOF Osteoneurogen Inc. (KR) 2019-01-02 — — EP disclosed
Send feedback